Skip to main content
 This program is no longer active, however there are other versions of this program in which you may be interested.

Advances in Diagnosis and Treatment of Neuromuscular & Neurodegenerative Disorders: What's Changed in 2016?, 10/18/2016 12:00:00 AM CDT, Digital Seminar More info »
Advances in Diagnosis and Treatment of Neuromuscular & Neurodegenerative Disorders: What's Changed in 2016?, 10/18/2016 12:00:00 AM CDT, DVD More info »
Not Found
Live Webcast

Advances in Diagnosis and Treatment of Neuromuscular & Neurodegenerative Disorders: What's Changed in 2016?


Speaker:
Susan Fralick-Ball, PsyD, MSN, CLNC, CH
Duration:
Full Day
Format:
Audio and Video
Product Code:
LWC077075
Brochure Code:
PLW47439
Media Type:
Live Webcast - Also available: Digital Seminar | DVD

Dates

Normal Price:      $249.99 - Now:  $49.99 - Exclusive offer when combined with this live training.

Description

New Findings, Updates, and Treatments:

  • Innovative Treatment Regiments for PTs, OTs and SLPs
  • Genomic Markers for Diagnosis and Treatment
  • Medications vs. Hands-On Treatment
  • Symptom Management and Long-Term Care

Multiple Sclerosis, Parkinson’s Disease & Chameleons, Myasthenia Gravis vs. Lambert-Eaton Myasthenic Syndrome, Muscular Dystrophy, Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculopathy, Amyotrophic Lateral Sclerosis/ Motor Neuron Disease

These disorders remain the nation’s leading causes of disability. They are devastating and costly. Due to the aging population, the incidence of these disorders is increasing rapidly. There is a need to provide early diagnosis and apply effective therapies for these disorders. Join expert, Susan Fralick-Ball, PsyD, MSN, CLNC, CH, to learn new strategies for pathophysiologic changes, clinical manifestations, and diagnostic studies for each of these disorders. Gain information on the latest innovative drugs that are geared to slow or stop the disorder progression. Through an engaging presentation style and enlightening case studies, Dr. Fralick-Ball will enhance your knowledge regarding current practice issues. The evidence-based content will improve outcomes for your patients with neuromuscular and neurodegenerative disorders.

OUTLINE

Multiple Sclerosis

  • 4 classifications
  • Risk factors: Low Vitamin D, abnormal lipid metabolism
  • Making the diagnosis 1-2-3
    • Neuromyelitis Optica, nystagmus
    • Genomic markers
  • MRI plain and 3-D
  • Treating multiple complications
  • Get Dancing and Get on a Bike exercises for MS
  • Medication updates 2016
  • Case Study

Parkinson’s Disease

  • Degeneration, Decline, and Autonomic Disease
    • A Prion Disease?
  • T-R-A-P symptoms
  • Non-motor complications
  • Biomarkers, LRRK variants
  • Medical treatment
    • Medications
    • Neuroprotection
  • Surgical treatment
    • Palidotomy, Thalamotomy, DBS, Stem cell transplantation
  • New PT/OT/SP guidelines for early engagement
    • Bikes, boxing, Big & Loud programs, forced exercise
    • Electrical stimulation
  • PD chameleons
    • Essential Tremor
    • Progressive supranuclear palsy
    • Corticobasilar degeneration
  • Case Study

Myasthenia Gravis

  • Neuromuscular Junction Disorder
    • Autoimmune
    • T-cell interference at NMJ
  • Edrophonium (Enlon™) Test for Diagnosis
    • MG vs. Lambert-Eaton
  • Short-acting anticholinesterase inhibitors
  • Thymectomy
  • Crisis: Myasthenic vs. Cholinergic
  • Emergent Treatment: Steroids, IVIG, Plasma
  • Exchange
  • Case Study

Muscular Dystrophy

  • Symptoms & causes
  • Complications over time
  • Treatment: Medical and surgical
  • Case Study

Guillain-Barré Syndrome

  • Syndrome of peripheral demyelination
    • Ascending
    • Pure motor
    • Descending
    • Miller-Fisher
  • Early diagnosis, earlier recovery
  • Causes: Viral, bacterial, surgical, vaccines, hyponatremia
  • Medical treatment: The Big 3 (steroids, IVIG, Plasmapheresis)
  • PT/OT/ST/Psych guidelines
  • Case Study

Chronic Inflammatory Demyelinating Polyneuropathy/radiculopathy

  • The elusive diagnosis dilemma
    • Symptoms, testing
  • Medical treatment for the short- and long-term
    • Living with neuropathic pain
    • Medication, spinal/brain stimulation
  • Best PT/OT guidelines
  • Case Study

Amyotrophic Lateral Sclerosis

  • Degeneration of the motor neurons
  • Genetic or generic disease?
    • Rule out everything else
  • Risk factors and neuroprotection
  • Medications help the complications
    • Alternative treatments
    • Stem cell research
  • Palliative considerations

OBJECTIVES

  1. Specify the preeminent medication management for multiple sclerosis and its complications
  2. Examine the most recent diagnostic indicators for multiple sclerosis
  3. Summarize your knowledge of Parkinson’s disease and its variants
  4. Describe common side effects to Parkinson’s medications
  5. Analyze the pros and cons of medications vs. hands-on treatment for these diseases
  6. Outline the differences in myasthenic and cholinergic crisis
  7. Explain the long-term care for muscular dystrophies
  8. Interpret the syndrome variants for the patient with Guillain-Barré and CIDP
  9. Summarize the symptom management for the patient with Amyotrophic Lateral Sclerosis
  10. Identify newly found genomic markers for diagnosis and treatment of these disorders

Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to PESI, Inc., PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.

ADA Needs

PESI would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 800-844-8260.

Credit


* Credit Note - *

NOTE: Tuition includes one free CE Certificate (participant will be able to print the certificate of completion after passing the on-line post-test (80% passing score) and completing the evaluation). 

Continuing Education Information: Listed below are the continuing education credit(s) currently available for this live interactive webcast. This webcast is a broadcast of a live event. You will be able to type questions to the speaker. The speaker will see the questions and address them during the presentation as time allows. Please note, your state licensing board dictates whether web based activities are an acceptable form of continuing education. Please refer to your state rules and regulations. If your profession is not listed, please contact your licensing board to determine your continuing education requirements and check for reciprocal approval. For other credit inquiries not specified below, please contact cepesi@pesi.com or 800-844-8260 before the event.

Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of your profession.  As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice in accordance with and in compliance with your profession's standards.

For Planning Committee disclosures, please see the statement above.  For speaker disclosures, please see the faculty biography.

CE Information is based on 100% attendance.

 


Pharmacology Nurse Practitioners

This program offers instructional minutes of pharmacology content which is designed to qualify for 1.0 contact hours toward your pharmacology requirement. 


Nurses, Nurse Practitioners, and Clinical Nurse Specialists

PESI, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Nurses in full attendance will earn 6.0 contact hours.


California Nurses

PESI, Inc. is a provider approved by the California Board of Registered Nursing, Provider Number 17118 for 6.0 contact hours. Full attendance is required. No partial contact hours will be issued for partial attendance. 


Florida Nurses

PESI, Inc. is an approved provider with the Florida Board of Nursing, Provider # FBN2858. This course qualifies for 6.0 contact hours. 

CE Broker


Iowa Nurses

PESI, Inc. is an approved provider by the Iowa Board of Nursing. Provider #: 346. Full attendance at this activity qualifies for 7.2 contact hours. Full attendance in the activity is required; no partial contact hours will be issued for partial attendance. These contact hours are used for your license renewal. Please email cepesi@pesi.com with your license number, include the webcast title, speaker name and date. PESI must have this number on file in order for your hours to be valid for the webcast.


Florida Occupational Therapists & Occupational Therapy Assistants

PESI, Inc. is an approved provider with the Florida Board of Occupational Therapy. Provider Number #50-399. This course qualifies for 6.0 continuing education credits.

CE Broker


Occupational Therapists & Occupational Therapy Assistants

AOTA

PESI, Inc. is an AOTA Approved Provider of continuing education. Provider #: 3322. Full attendance at this course qualifies for 6.0 contact hours or  CEUs in the Category of . Partial credit will be issued for partial attendance. The assignment of AOTA CEUs does not imply endorsement of specific course content, products, or clinical procedures by AOTA. Course Level: .


Physical Therapists & Physical Therapist Assistants

This activity consists of 6.0 clock hours of instruction that is applicable for physical therapists. This certificate is proof of your attendance. Please retain it in your records or use for submission as proof of completion when required.


California Physical Therapists & Physical Therapist Assistants

California Physical Therapists

PESI, Inc. is recognized by the Physical Therapy Board of California as an approval agency to approve providers. This course will qualify for 6.0 continuing competency hours.


Texas Physical Therapists & Physical Therapist Assistants

This activity is provided by the Texas Board of Physical Therapy Examiners Accredited Provider #2106032TX and meets continuing competence requirements for physical therapist and physical therapist assistant licensure renewal in Texas. This activity will provide 6.0 CCUs. The assignment of Texas PT CCUs does not imply endorsement of specific course content, products, or clinical procedures by TPTA or TBPTE. Full attendance is required; no partial credits will be offered for partial attendance.


Illinois Physical Therapists & Physical Therapist Assistants

PESI, Inc. is a Registered Physical Therapy Continuing Education Sponsor through the State of Illinois Department of Financial and Professional Regulation, Division of Professional Regulation. License #: 216.000270. This course qualifies for 6.0 CE Credit Hours.


New York Physical Therapists & Physical Therapist Assistants

PESI, Inc. is recognized by the New York State Education Department, State Board for Physical Therapy as an approved provider for physical therapy and physical therapy assistant continuing education. This course qualifies for 7.2 contact hours. 


Physician Assistants

AAPA Logo

This program has been reviewed and is approved for a maximum of 6.0 hours of clinical Category I CME credit by the American Academy of Physician Assistant Review Panel. Physician assistants should claim only those hours actually spent participating in the CME activity. This program was planned in accordance with AAPA’s CME Standards for Live Programs and for Commercial Support of Live Programs.


California Speech-Language Pathologists and Audiologists

PESI, Inc. is an approved provider with the California Speech-Language Pathology and Audiology Board, #PDP 319. This course meets the qualifications for 6.0 hours of continuing professional development credit for Speech-Language Pathologists or Audiologists, as required by the California Speech-Language Pathology and Audiology Board.


Kansas Speech-Language Pathologists or Audiologists

Approved for 7.0 continuing education clock hours for Kansas licensed Speech-Language Pathologists by the Kansas Department for Aging and Disability Services.


Speech-Language Pathologists & Audiologists

ASHA

This live course is offered for ASHA CEUs ( level, area).

** Please note that Speech-Language Pathologists & Audiologists must complete the post-test and evaluation within two weeks of attending the live webcast if they would like their participation submitted to the ASHA CE Registry. Detailed instructions will be provided the day of the program under the Handouts section of the online program.


Other Professions

This activity qualifies for 6.0 continuing education minutes as required by many national, state and local licensing boards and professional organizations. Save your activity advertisement and certificate of completion, and contact your own board or organization for specific requirements. 



Handouts/Brochure

Additional Info

Access Period for Live Webcast

For live CE credit, you must watch the live webcast in its entirety at its scheduled time. You will have access for 90 days after the program for review. 


Webcast Schedule

Please note: There will be a lunch and two 15-minute breaks; one in the morning and one in the afternoon. Lunch and break times will be announced by the speaker and at their discretion.


Target Audience

Nurses, Occupational Therapists & Occupational Therapy Assistants, Physical Therapists/Physical Therapist Assistants, Physician Assistants, Speech-Language Pathologists

Reviews

5
4
3
2
1

Overall:      5

Total Reviews: 1

Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.

ADA Needs
We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.

PESI Mobile App

Access CE trainings on your phone or tablet through our free mobile app. Choose video or audio-only versions of online courses from the world’s best instructors, and complete your CE requirements anywhere, anytime, at your own pace.

https://cdn.pesi23.com/images/android.png     https://cdn.pesi23.com/images/iphone.png

Please wait ...

Back to Top